
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) related to its sale to SERB Pharmaceuticals for $8.60 per share in cash for each share of Y-mAbs stock.
Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) related to its sale to SERB Pharmaceuticals for $8.60 per share in cash for each share of Y-mAbs stock.